Harmon Cyrus
SEC Form 4 insider trading activity
Harmon Cyrus has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 27, 2026.
On the most recent filing, Harmon Cyrus is listed as Director at Olema Pharmaceuticals, Inc. Inside the rolling window, Harmon Cyrus reported no open-market purchases and 5 open-market sales totaling $744K in OLMA. The largest disclosed transaction in the window is a sale of 10,000 OLMA shares on Jan 20, 2026, worth $269K.
Companies traded
Other insiders at OLMA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$744K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 18, 2025 | OLMA | Sale | $26K |
| Sep 18, 2025 | OLMA | Sale | $83K |
| Sep 16, 2025 | OLMA | Sale | $15K |
| Sep 16, 2025 | OLMA | Sale | $80K |
Frequently asked questions
How many SEC Form 4 filings has Harmon Cyrus made?
Harmon Cyrus has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Harmon Cyrus trade?
Harmon Cyrus has filed SEC Form 4 disclosures for 1 company, including OLMA.
When was Harmon Cyrus's most recent SEC Form 4 filing?
Harmon Cyrus's most recent SEC Form 4 filing on Tracefour is dated Jul 27, 2026.
What is Harmon Cyrus's total buy and sell value in the current window?
Inside the rolling retention window, Harmon Cyrus bought $0 and sold $744K based on SEC Form 4 filings.
What was Harmon Cyrus's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 OLMA shares on 2026-01-20, worth $269K, per SEC Form 4 filings.